Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19

Additional doses of etesevimab will be paired with existing bamlanivimab purchased by the U.S. government INDIANAPOLIS , Sept. 15, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today announced an additional purchase by the U.S. government for its neutralizing antibody therapies authorized